DE60025830D1 - Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung - Google Patents

Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung

Info

Publication number
DE60025830D1
DE60025830D1 DE60025830T DE60025830T DE60025830D1 DE 60025830 D1 DE60025830 D1 DE 60025830D1 DE 60025830 T DE60025830 T DE 60025830T DE 60025830 T DE60025830 T DE 60025830T DE 60025830 D1 DE60025830 D1 DE 60025830D1
Authority
DE
Germany
Prior art keywords
healing
fusion polypeptides
matrix application
tissue
wound healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025830T
Other languages
English (en)
Other versions
DE60025830T2 (de
Inventor
L Hall
Marcel Nimni
Erlinda Gordon
W Beart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Application granted granted Critical
Publication of DE60025830D1 publication Critical patent/DE60025830D1/de
Publication of DE60025830T2 publication Critical patent/DE60025830T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0679—Cells of the gastro-intestinal tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
DE60025830T 1999-07-21 2000-07-21 Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung Expired - Lifetime DE60025830T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14548899P 1999-07-21 1999-07-21
US145488P 1999-07-21
PCT/US2000/020055 WO2001007059A1 (en) 1999-07-21 2000-07-21 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing

Publications (2)

Publication Number Publication Date
DE60025830D1 true DE60025830D1 (de) 2006-04-13
DE60025830T2 DE60025830T2 (de) 2006-11-02

Family

ID=22513353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025830T Expired - Lifetime DE60025830T2 (de) 1999-07-21 2000-07-21 Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung

Country Status (7)

Country Link
US (2) US7459541B2 (de)
EP (1) EP1223953B1 (de)
AT (1) ATE316980T1 (de)
AU (1) AU764520B2 (de)
CA (1) CA2378925C (de)
DE (1) DE60025830T2 (de)
WO (1) WO2001007059A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU764520B2 (en) * 1999-07-21 2003-08-21 University Of Southern California Matrix-targeted fusion polypeptides for tissue regeneration and wound healing
US20070178066A1 (en) 2003-04-21 2007-08-02 Hall Frederick L Pathotropic targeted gene delivery system for cancer and other disorders
US8802396B2 (en) 2005-12-26 2014-08-12 Yantai Zhenghai Bio-Technology Co., Ltd. Activated collagen scaffold materials and their special fused active restoration factors
CN100400549C (zh) * 2006-05-24 2008-07-09 中国科学院遗传与发育生物学研究所 与胶原特异结合的神经生长因子及其编码基因与应用
NZ573576A (en) * 2006-06-08 2011-01-28 Astrazeneca Ab Benzimidazoles and their use for the treatment of diabetes
CA2749858C (en) * 2009-01-16 2017-12-12 Geistlich Pharma Ag Method and membrane for skin regeneration
US20100322977A1 (en) * 2009-06-05 2010-12-23 The Ohio State University Research Foundation Biomaterials, compositions, and methods
JP5737597B2 (ja) * 2009-11-19 2015-06-17 浙江大学 非天然コラーゲン様タンパク質及びその応用
BR112012029611A2 (pt) 2010-05-21 2017-07-25 Merrimack Pharmaceuticals Inc proteína de fusão biespecífica, composição farmacêutica, método de tratamento de dano ao tecido em um indivíduo, método de promoção da regeração ou sobrevivência do tecido em um indivíduo e molécula de ácido nucleico
US10279007B2 (en) 2010-11-15 2019-05-07 Oxygenetix Institute, Inc. Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
CN102115495B (zh) * 2010-12-24 2012-07-04 中国人民解放军第四军医大学 胶原靶向治疗增生性瘢痕蛋白药物的制备及应用
US10420820B2 (en) * 2014-09-29 2019-09-24 Counterpoint Biomedia LLC Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides
CN115960249A (zh) 2015-10-02 2023-04-14 银溪制药股份有限公司 用于组织修复的双特异性治疗性蛋白质
US10913779B2 (en) * 2017-01-25 2021-02-09 Counterpoint Biomedica Llc Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infections
WO2019173289A1 (en) * 2018-03-05 2019-09-12 The University Of Chicago Methods and compositions for treating cancer with ecm-affinity peptides linked to cytokines

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980289A (en) * 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US6653291B1 (en) * 1992-11-13 2003-11-25 Purdue Research Foundation Composition and method for production of transformed cells
US5704910A (en) 1995-06-05 1998-01-06 Nephros Therapeutics, Inc. Implantable device and use therefor
US5800811A (en) * 1995-06-06 1998-09-01 Hall; Frederick L. Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site
US6352972B1 (en) * 1995-06-06 2002-03-05 Marcel E. Nimni Bone morphogenetic proteins and their use in bone growth
WO1998044938A1 (en) * 1997-04-10 1998-10-15 University Of Southern California Modified proteins which bind extracellular matrix components
US6004798A (en) 1997-05-14 1999-12-21 University Of Southern California Retroviral envelopes having modified hypervariable polyproline regions
US6387663B1 (en) * 1998-07-31 2002-05-14 University Of Southern California Targeting pharmaceutical agents to injured tissues
WO2000020449A2 (en) * 1998-10-07 2000-04-13 Stryker Corporation MODIFIED TGF-β SUPERFAMILY PROTEINS
US20020102709A1 (en) * 1999-02-19 2002-08-01 Tetsuya Ishikawa Collagen-binding physiologically active polypeptide
IL147722A0 (en) * 1999-07-20 2002-08-14 Univ Southern California Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
AU764520B2 (en) * 1999-07-21 2003-08-21 University Of Southern California Matrix-targeted fusion polypeptides for tissue regeneration and wound healing

Also Published As

Publication number Publication date
DE60025830T2 (de) 2006-11-02
CA2378925C (en) 2010-04-06
US7459541B2 (en) 2008-12-02
EP1223953A1 (de) 2002-07-24
ATE316980T1 (de) 2006-02-15
WO2001007059A1 (en) 2001-02-01
AU764520B2 (en) 2003-08-21
US20090093407A1 (en) 2009-04-09
US20050037469A1 (en) 2005-02-17
WO2001007059A9 (en) 2002-09-06
AU6118000A (en) 2001-02-13
CA2378925A1 (en) 2001-02-01
EP1223953B1 (de) 2006-02-01
EP1223953A4 (de) 2002-11-27

Similar Documents

Publication Publication Date Title
DE60025830D1 (de) Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung
PL377553A1 (pl) Peptydy oraz pokrewne cząsteczki modulujące aktywność czynnika wzrostu nerwów
ATE467425T1 (de) Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben
MXPA04001334A (es) Materiales y metodos para promover la reparacion de tejido nervioso.
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
DE69718633D1 (de) Mikrokeratom zur Hornhautchirurgie mittels Laser
DE60214477D1 (de) Implantat zur Regeneration von Knorpelgewebe
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
ATE515268T1 (de) Verwendung von op-1 zur behandlung von knorpeldefekten
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
WO2003072593A3 (en) Bone targeting peptides
ATE444086T1 (de) Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
DE60108857D1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
ATE220918T1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
ATE497786T1 (de) Zusammensetzungen und kits zur erhöhung der abgabe von therapeutischen mitteln an zellen
ATE397077T1 (de) Substraten und nachweise zur wirksamkeit von beta-secretase
DE60000501D1 (de) Verwendung von melanomhemmendem faktor zur reparatur von knorpelgewebe und knochen
PT866870E (pt) Proteinas de fusao factor tecidual-dominio de kunitz como inibidores do factor viia
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
DE50304342D1 (de) Beleuchtung für Operationsmikroskope zum Schutz von menschlichem Gewebe
BR9811796A (pt) Veìculo de terapia genética compreendendo tecido de revestimento dérmico
ATE491442T1 (de) 1-phenyl-2- dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
PT1227826E (pt) Metodos e composicoes para o suporte regeneracao e reparacao de tecidos conjuntivos
DE60022776D1 (de) Verfahren und material zur hämostase bei knochen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition